Respiratory syncytial virus (RSV) was related to 190,000 to 350,000 hospitalizations from July 1, 2024, to June 30, 2025, in addition to 10,000 to 23,000 deaths, based on knowledge printed final month by the Facilities for Illness Management and Prevention (CDC).
Throughout the identical time, COVID-19 was related to an estimated 290,000 to 450,000 hospitalizations and 34,000 to 53,000 deaths.
COVID-19 continues to peak twice a yr, based on the CDC. About 18% of COVID-19 instances throughout this era have been reported in August, with a smaller surge in early January, when practically 7% of instances have been reported.
The very best COVID-19 hospitalization charges have been in folks age 75 and older, with 933 hospitalizations per 100,000 folks; infants below six months, with 286 hospitalizations per 100,000 folks; and adults age 65 to 74, with 274 hospitalizations per 100,000 folks.
All SARS-CoV-2 viruses sequenced throughout this time are descendants of the JN.1 variant, making final yr the primary season with out a new dominant pressure substitute because the starting of the COVID-19 pandemic.
The info have been printed February 19 within the CDC’s flagship publication, Morbidity and Mortality Weekly Report.
RSV poses the best threats to the youngest and oldest folks
Though most individuals with RSV develop signs just like a chilly, some can turn into very sick and die from the virus, which tends to unfold in fall and winter.
RSV-associated hospitalization charges have been highest amongst infants below 1 yr previous, at a charge of 1,117 instances per 100,000 folks, adopted by youngsters age 12 to 23 months (770 instances per 100,000 folks) and adults age 75 or older (427 instances per 100,000).
Throughout this time interval, the share of constructive RSV assessments peaked at 11% in the course of the week ending December 21, 2024. RSV was reported at epidemic ranges from November 9, 2024, to March 29, 2025.
.jpg)